Infliximab biosimilar only moderately less expensive in Medicare Part DSeptember 6, 2018Psoriatic Arthritis
Psoriasis registry study provides more data on infliximab’s infection riskAugust 16, 2018Psoriatic Arthritis
Elderly patients with psoriasis can benefit from biologics with low rates of adverse eventsJune 29, 2018Psoriatic Arthritis
